Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Melanie Joy

Concepts (374)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Glomerulonephritis
7
2016
61
3.030
 Why?
Cisplatin
6
2018
283
2.420
 Why?
Glomerulosclerosis, Focal Segmental
6
2015
32
2.290
 Why?
Mycophenolic Acid
7
2016
95
2.270
 Why?
Kidney Diseases
9
2016
389
2.150
 Why?
Acute Kidney Injury
9
2021
568
2.130
 Why?
Kidney
11
2021
1121
1.860
 Why?
Lupus Nephritis
4
2013
46
1.830
 Why?
Cyclophosphamide
4
2016
240
1.810
 Why?
Organic Anion Transporters
2
2021
31
1.680
 Why?
Pharmaceutical Preparations
4
2021
147
1.560
 Why?
Kidney Failure, Chronic
13
2009
420
1.550
 Why?
Membrane Transport Proteins
3
2017
163
1.370
 Why?
Enzyme Inhibitors
4
2010
944
1.250
 Why?
Vasculitis
6
2012
81
1.200
 Why?
Glucuronides
4
2015
26
1.140
 Why?
Antineoplastic Agents
5
2018
2033
1.110
 Why?
Antibodies, Antineutrophil Cytoplasmic
5
2010
28
0.990
 Why?
Aryl Hydrocarbon Hydroxylases
3
2012
58
0.980
 Why?
Uremia
1
2021
19
0.950
 Why?
Proteinuria
6
2017
100
0.950
 Why?
Adalimumab
4
2015
31
0.940
 Why?
Glomerular Filtration Rate
6
2018
491
0.930
 Why?
Renal Dialysis
11
2007
316
0.920
 Why?
Creatinine
11
2021
432
0.910
 Why?
Rituximab
2
2018
138
0.910
 Why?
Calcineurin Inhibitors
3
2016
75
0.830
 Why?
Anti-Inflammatory Agents
3
2013
448
0.830
 Why?
Glomerulonephritis, Membranous
1
2018
3
0.820
 Why?
Membranes, Artificial
3
2018
74
0.810
 Why?
Hemoperfusion
1
2018
5
0.800
 Why?
Immunosuppressive Agents
4
2010
864
0.790
 Why?
Lanthanum
4
2006
11
0.780
 Why?
Hyperphosphatemia
1
2018
13
0.780
 Why?
Glucuronosyltransferase
3
2015
17
0.760
 Why?
Anemia
3
2009
148
0.750
 Why?
Kidney Tubules, Proximal
2
2016
93
0.740
 Why?
Pharmacogenomic Variants
1
2017
33
0.730
 Why?
Simvastatin
1
2017
69
0.720
 Why?
Oleanolic Acid
1
2016
8
0.700
 Why?
Hyperparathyroidism, Secondary
3
2007
13
0.690
 Why?
Terfenadine
2
2013
2
0.690
 Why?
Autoimmune Diseases
3
2018
422
0.670
 Why?
Azathioprine
1
2016
55
0.670
 Why?
Humans
71
2021
104249
0.660
 Why?
Renal Insufficiency, Chronic
2
2013
373
0.650
 Why?
Enzymes
1
2016
77
0.640
 Why?
Pharmacogenetics
1
2016
153
0.600
 Why?
Brain Diseases
1
2016
143
0.600
 Why?
Oxidoreductases, N-Demethylating
2
2012
18
0.580
 Why?
Flurbiprofen
1
2013
4
0.580
 Why?
Adult
30
2021
30359
0.570
 Why?
Liver Diseases
1
2016
270
0.570
 Why?
Metabolic Clearance Rate
7
2018
160
0.560
 Why?
Pharmacokinetics
2
2012
44
0.550
 Why?
Biomarkers
7
2021
3163
0.550
 Why?
Middle Aged
28
2021
27633
0.530
 Why?
Hypothyroidism
1
2013
74
0.530
 Why?
Leukocytes
1
2014
269
0.520
 Why?
Multidrug Resistance-Associated Proteins
3
2017
32
0.520
 Why?
Half-Life
5
2018
197
0.510
 Why?
Serum Albumin
5
2012
151
0.510
 Why?
Metabolic Networks and Pathways
1
2013
163
0.500
 Why?
Antibodies, Monoclonal, Humanized
3
2013
585
0.500
 Why?
Cytochrome P-450 Enzyme System
2
2016
149
0.500
 Why?
Male
37
2021
58392
0.490
 Why?
Female
36
2018
59707
0.480
 Why?
Heptanoic Acids
3
2011
72
0.480
 Why?
Patient Care Team
2
2007
527
0.470
 Why?
Kidney Transplantation
3
2009
432
0.470
 Why?
Vitamin D
2
2021
326
0.460
 Why?
Losartan
2
2011
15
0.460
 Why?
Naphthalenes
3
2007
51
0.460
 Why?
Nephrology
2
2007
24
0.450
 Why?
Aged
18
2018
18934
0.450
 Why?
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
1
2010
14
0.440
 Why?
Bupropion
1
2010
32
0.440
 Why?
Tacrolimus
2
2016
193
0.440
 Why?
Organic Cation Transporter 2
2
2021
13
0.430
 Why?
Pyrroles
3
2011
198
0.430
 Why?
Antidepressive Agents, Second-Generation
1
2010
37
0.430
 Why?
Phosphates
2
2018
176
0.430
 Why?
Anticholesteremic Agents
3
2011
136
0.430
 Why?
Epithelial Cells
1
2016
1008
0.420
 Why?
RNA, Messenger
3
2016
2914
0.420
 Why?
Organic Cation Transport Proteins
2
2021
38
0.420
 Why?
Dose-Response Relationship, Drug
8
2016
2242
0.390
 Why?
Hypercholesterolemia
2
2007
97
0.380
 Why?
Thiazolidinediones
1
2008
160
0.360
 Why?
Severity of Illness Index
2
2013
2653
0.360
 Why?
Milrinone
2
2018
24
0.360
 Why?
Neoplasms
3
2018
1913
0.350
 Why?
Lipoproteins
1
2007
170
0.350
 Why?
Polymorphism, Single Nucleotide
3
2017
1979
0.340
 Why?
Vitamins
1
2007
123
0.330
 Why?
Biological Transport
4
2021
430
0.330
 Why?
Pharmacists
2
2007
243
0.330
 Why?
Antibodies, Monoclonal
2
2011
1272
0.330
 Why?
Erythropoietin
2
2007
90
0.330
 Why?
Ambulatory Care
2
2007
439
0.330
 Why?
Area Under Curve
4
2018
343
0.330
 Why?
Granulomatosis with Polyangiitis
1
2005
31
0.320
 Why?
Glycated Hemoglobin A
2
2002
709
0.320
 Why?
Prodrugs
1
2005
43
0.320
 Why?
Antihypertensive Agents
1
2009
443
0.310
 Why?
NF-E2-Related Factor 2
2
2016
73
0.310
 Why?
Case Management
1
2005
69
0.310
 Why?
Organ Transplantation
1
2007
153
0.310
 Why?
Aniline Compounds
1
2004
60
0.300
 Why?
Chronic Disease
7
2012
1686
0.300
 Why?
Hemofiltration
3
2000
39
0.300
 Why?
Quality Assurance, Health Care
1
2007
384
0.290
 Why?
Treatment Outcome
10
2013
8608
0.290
 Why?
Regression Analysis
3
2018
1158
0.290
 Why?
Cyclosporine
1
2005
276
0.280
 Why?
HEK293 Cells
4
2021
640
0.270
 Why?
Carcinoma, Renal Cell
2
2015
142
0.270
 Why?
Blood Pressure
1
2009
1654
0.260
 Why?
Chromatography, Liquid
3
2021
372
0.250
 Why?
Cytochrome P-450 CYP2C9
2
2013
22
0.250
 Why?
Cytochrome P-450 CYP2B6
2
2012
11
0.250
 Why?
Young Adult
7
2021
10261
0.240
 Why?
Vancomycin
2
2021
66
0.240
 Why?
Antiemetics
1
2021
40
0.240
 Why?
Biomedical Research
1
2007
574
0.240
 Why?
Genotype
3
2014
2038
0.240
 Why?
Kidney Neoplasms
2
2015
285
0.230
 Why?
Cholecalciferol
1
2021
45
0.230
 Why?
Tissue Distribution
2
2013
409
0.230
 Why?
Cytochrome P-450 CYP3A
2
2013
78
0.220
 Why?
Exosomes
1
2021
72
0.220
 Why?
Administration, Oral
4
2018
812
0.210
 Why?
Pilot Projects
4
2018
1323
0.210
 Why?
Age Factors
3
2015
3221
0.210
 Why?
Polymorphism, Genetic
2
2016
781
0.200
 Why?
Tricarboxylic Acids
1
2018
13
0.200
 Why?
Quality of Life
1
2009
1817
0.200
 Why?
Prospective Studies
5
2018
5605
0.200
 Why?
Follow-Up Studies
6
2011
4685
0.200
 Why?
Off-Label Use
1
2018
42
0.200
 Why?
Hematinics
2
2009
22
0.190
 Why?
Child
8
2016
15648
0.190
 Why?
Clonazepam
1
1997
6
0.190
 Why?
Kidney Function Tests
3
2017
153
0.190
 Why?
Indican
1
2017
1
0.190
 Why?
GABA Modulators
1
1997
17
0.190
 Why?
Restless Legs Syndrome
1
1997
21
0.190
 Why?
Glutathione S-Transferase pi
1
2017
8
0.190
 Why?
Renal Replacement Therapy
1
1998
54
0.190
 Why?
Anti-Anxiety Agents
1
1997
52
0.190
 Why?
Adsorption
1
2018
157
0.190
 Why?
Thyroid Diseases
2
2007
36
0.190
 Why?
Parathyroid Hormone
4
2007
105
0.190
 Why?
Osteoporosis
1
2000
186
0.180
 Why?
Infusions, Intravenous
1
2018
440
0.180
 Why?
Fructose
1
2018
179
0.180
 Why?
Xenobiotics
1
2017
27
0.180
 Why?
Adolescent
9
2015
17541
0.170
 Why?
Cation Transport Proteins
1
2017
114
0.170
 Why?
Phosphorus
3
2006
92
0.170
 Why?
Subcutaneous Absorption
1
2015
1
0.170
 Why?
Hemoglobins
2
2009
272
0.170
 Why?
Tumor Necrosis Factor-alpha
2
2013
1194
0.170
 Why?
Gene Expression Regulation
2
2016
2566
0.170
 Why?
Adrenal Cortex Hormones
1
2000
497
0.160
 Why?
Hydroxychloroquine
1
2016
47
0.160
 Why?
Drug Interactions
1
2017
468
0.160
 Why?
Blood-Brain Barrier
1
2016
105
0.160
 Why?
Phthalimides
1
2015
1
0.160
 Why?
Cell Survival
2
2016
1106
0.160
 Why?
Darbepoetin alfa
2
2007
5
0.160
 Why?
Injections, Subcutaneous
1
2015
175
0.160
 Why?
Proteomics
1
2021
708
0.160
 Why?
Societies, Pharmaceutical
2
2005
24
0.160
 Why?
Blood Glucose
2
2018
1689
0.160
 Why?
Isoquinolines
1
2015
47
0.160
 Why?
Drug Therapy
1
1995
80
0.150
 Why?
Reactive Oxygen Species
1
2017
521
0.150
 Why?
Hepatocytes
1
2016
220
0.150
 Why?
Cholesterol, LDL
2
2007
312
0.150
 Why?
RNA Isoforms
1
2013
3
0.150
 Why?
C-Reactive Protein
2
2007
341
0.150
 Why?
Tenofovir
1
2016
180
0.150
 Why?
Breath Tests
1
2013
82
0.140
 Why?
Case-Control Studies
3
2013
3225
0.140
 Why?
Critical Care
1
1998
441
0.140
 Why?
Angiotensin II Type 1 Receptor Blockers
2
2011
39
0.130
 Why?
Tandem Mass Spectrometry
2
2021
421
0.130
 Why?
Myocytes, Cardiac
1
2017
432
0.130
 Why?
Complement Activation
1
2015
306
0.130
 Why?
Liver
2
2018
1802
0.130
 Why?
Treatment Failure
1
2013
328
0.130
 Why?
Alternative Splicing
1
2013
204
0.120
 Why?
Cells, Cultured
2
2021
4339
0.120
 Why?
Intracellular Signaling Peptides and Proteins
1
2015
432
0.120
 Why?
Drug Resistance
2
2011
200
0.120
 Why?
Galactose
1
2011
25
0.120
 Why?
Critical Illness
1
2016
481
0.120
 Why?
Animals
8
2021
34264
0.120
 Why?
Diabetes Mellitus
1
1998
852
0.110
 Why?
Cephalosporins
2
2000
30
0.110
 Why?
Drug Administration Schedule
2
2003
838
0.110
 Why?
Inflammation
1
2021
2171
0.110
 Why?
Randomized Controlled Trials as Topic
3
2004
1040
0.110
 Why?
Stereoisomerism
1
2010
133
0.110
 Why?
Fetus
1
2013
623
0.110
 Why?
Lupus Erythematosus, Systemic
1
2012
254
0.110
 Why?
Diabetes Mellitus, Type 2
1
2002
1796
0.110
 Why?
Anti-Allergic Agents
1
2009
49
0.100
 Why?
Quality Indicators, Health Care
1
2012
290
0.100
 Why?
Body Surface Area
1
2008
23
0.100
 Why?
Anti-Bacterial Agents
1
1998
1243
0.100
 Why?
Calcium
4
2005
1250
0.100
 Why?
Cholesterol
2
2007
376
0.100
 Why?
Mass Spectrometry
1
2012
755
0.100
 Why?
Promoter Regions, Genetic
1
2013
1260
0.100
 Why?
Hepatitis A Virus Cellular Receptor 1
2
2018
30
0.100
 Why?
Patient Safety
1
2012
311
0.100
 Why?
Antithyroid Agents
1
2007
12
0.100
 Why?
Gene Expression
3
2021
1525
0.100
 Why?
Apolipoprotein A-I
1
2007
27
0.100
 Why?
Renal Insufficiency
1
2009
110
0.090
 Why?
Steroids
1
2008
137
0.090
 Why?
Statistics, Nonparametric
1
2009
463
0.090
 Why?
Gene Frequency
1
2009
552
0.090
 Why?
Canada
1
2008
301
0.090
 Why?
Apolipoproteins B
1
2007
55
0.090
 Why?
Pharmacy
1
2007
21
0.090
 Why?
Chromatography, High Pressure Liquid
1
2010
672
0.090
 Why?
Parathyroidectomy
1
2007
7
0.090
 Why?
Lipoprotein(a)
1
2007
41
0.090
 Why?
Ergocalciferols
1
2007
14
0.090
 Why?
Kidney Tubules, Distal
1
2007
1
0.090
 Why?
Chronic Kidney Disease-Mineral and Bone Disorder
1
2007
10
0.090
 Why?
Ferrous Compounds
1
2007
24
0.090
 Why?
Linear Models
1
2010
876
0.090
 Why?
Aged, 80 and over
3
2017
6518
0.090
 Why?
Models, Biological
1
2015
1842
0.090
 Why?
Calcitriol
1
2007
50
0.090
 Why?
Child, Preschool
3
2011
9106
0.090
 Why?
Fibrinogen
1
2007
149
0.090
 Why?
Polysaccharides
1
2007
77
0.090
 Why?
Diabetes Mellitus, Type 1
1
2002
2820
0.090
 Why?
Staining and Labeling
1
2007
170
0.090
 Why?
Drug Costs
1
2007
96
0.090
 Why?
Health Knowledge, Attitudes, Practice
1
1995
1148
0.090
 Why?
History, 21st Century
1
2007
220
0.090
 Why?
Hypertension
2
2005
1110
0.080
 Why?
History, 20th Century
1
2007
350
0.080
 Why?
Social Behavior
1
2009
304
0.080
 Why?
Phosphorus Metabolism Disorders
1
2005
2
0.080
 Why?
Role
1
2005
35
0.080
 Why?
Professional Role
1
2007
170
0.080
 Why?
Coloring Agents
1
2005
79
0.080
 Why?
Iron
1
2007
221
0.080
 Why?
Bone Diseases, Metabolic
1
2005
53
0.080
 Why?
Propylamines
1
2004
13
0.080
 Why?
Phenethylamines
1
2004
24
0.080
 Why?
Ethnic Groups
1
2009
623
0.080
 Why?
Angiotensin-Converting Enzyme Inhibitors
2
2011
215
0.080
 Why?
Cost-Benefit Analysis
1
2007
515
0.070
 Why?
Hyperlipidemias
1
2005
140
0.070
 Why?
Safety
2
2004
312
0.070
 Why?
Program Development
1
2007
386
0.070
 Why?
Phenotype
2
2010
2862
0.070
 Why?
Hyperparathyroidism
1
2003
10
0.070
 Why?
Peritoneal Dialysis, Continuous Ambulatory
1
2003
15
0.070
 Why?
Interdisciplinary Communication
1
2005
192
0.070
 Why?
European Continental Ancestry Group
1
2009
1337
0.070
 Why?
Brain
1
2016
2662
0.070
 Why?
Time Factors
3
2008
7066
0.070
 Why?
Comorbidity
2
2005
1537
0.070
 Why?
Feasibility Studies
1
2005
677
0.070
 Why?
Guidelines as Topic
1
2005
278
0.070
 Why?
Diabetes Complications
1
2005
243
0.070
 Why?
Nausea
1
2003
114
0.070
 Why?
Cell Membrane
1
2007
760
0.070
 Why?
Sex Factors
1
2009
1913
0.070
 Why?
Recurrence
1
2005
969
0.060
 Why?
Sleep
1
2009
647
0.060
 Why?
Double-Blind Method
2
2004
1609
0.060
 Why?
United States
2
2008
11035
0.060
 Why?
Drug Eruptions
1
2002
24
0.060
 Why?
Retrospective Studies
1
2017
10064
0.060
 Why?
Immunohistochemistry
1
2007
1854
0.060
 Why?
Serotonin 5-HT3 Receptor Antagonists
1
2021
2
0.060
 Why?
Madin Darby Canine Kidney Cells
1
2021
17
0.060
 Why?
Rats
2
2018
6717
0.060
 Why?
Cell Line
2
2021
2946
0.060
 Why?
Ceftazidime
1
2000
7
0.060
 Why?
Clinical Trials as Topic
1
2006
979
0.060
 Why?
Signal Transduction
1
2015
4845
0.060
 Why?
Ceftriaxone
1
2000
21
0.060
 Why?
Disease Progression
2
2005
2341
0.060
 Why?
Calcium, Dietary
1
2000
49
0.050
 Why?
Dogs
1
2021
492
0.050
 Why?
Molecular Structure
1
2021
495
0.050
 Why?
Logistic Models
1
2005
1984
0.050
 Why?
Quality of Health Care
1
2005
637
0.050
 Why?
Absorptiometry, Photon
1
2000
243
0.050
 Why?
Cohort Studies
1
2009
4560
0.050
 Why?
Acrylonitrile
1
1998
3
0.050
 Why?
Prevalence
1
2005
2225
0.050
 Why?
Incidence
1
2005
2317
0.050
 Why?
Biological Availability
1
2018
178
0.050
 Why?
Polymethyl Methacrylate
1
1998
24
0.050
 Why?
Acrylic Resins
1
1998
35
0.050
 Why?
Insulin-Like Growth Factor Binding Proteins
1
2018
27
0.050
 Why?
Tissue Inhibitor of Metalloproteinase-2
1
2018
15
0.050
 Why?
Lipocalin-2
1
2017
49
0.050
 Why?
Urea
1
1998
89
0.050
 Why?
Sulfones
1
1998
106
0.050
 Why?
Rats, Wistar
1
2018
444
0.050
 Why?
Surveys and Questionnaires
1
2009
4151
0.040
 Why?
Cardiotonic Agents
1
2018
137
0.040
 Why?
Diabetic Nephropathies
1
2000
255
0.040
 Why?
ROC Curve
1
2018
470
0.040
 Why?
Thoracic Surgery
1
2018
126
0.040
 Why?
Bone Density
1
2000
367
0.040
 Why?
Drug Monitoring
1
1998
218
0.040
 Why?
Cardiovascular Diseases
1
2007
1585
0.040
 Why?
Complement C5b
1
2015
4
0.040
 Why?
Risk Factors
3
2012
8467
0.040
 Why?
Pennsylvania
1
1995
103
0.040
 Why?
Isothiocyanates
1
2015
5
0.040
 Why?
Kelch-Like ECH-Associated Protein 1
1
2015
7
0.040
 Why?
Protein Transport
1
2017
448
0.040
 Why?
Acute Disease
1
1998
978
0.040
 Why?
Active Transport, Cell Nucleus
1
2015
120
0.040
 Why?
Polymers
1
1998
401
0.040
 Why?
Hep G2 Cells
1
2013
65
0.040
 Why?
Intestinal Mucosa
1
2018
498
0.040
 Why?
Mental Recall
1
1995
217
0.040
 Why?
Vasodilator Agents
1
2016
319
0.040
 Why?
Glucose
1
2018
819
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2015
384
0.030
 Why?
Organ Specificity
1
2013
321
0.030
 Why?
Exons
1
2013
318
0.030
 Why?
Insulin
1
2002
1972
0.030
 Why?
Carrier Proteins
1
2017
810
0.030
 Why?
Infant
2
2018
7629
0.030
 Why?
Cell Nucleus
1
2015
601
0.030
 Why?
Genetic Variation
1
2017
945
0.030
 Why?
Lisinopril
1
2011
18
0.030
 Why?
Medication Errors
1
2012
103
0.030
 Why?
Patient Compliance
1
1995
601
0.030
 Why?
Diagnostic Errors
1
2012
158
0.030
 Why?
Terminology as Topic
1
2012
219
0.030
 Why?
Practice Guidelines as Topic
2
2012
1525
0.030
 Why?
Limit of Detection
1
2009
72
0.030
 Why?
Patient Education as Topic
1
1995
753
0.030
 Why?
Calibration
1
2009
137
0.030
 Why?
Liver Neoplasms
1
2013
474
0.030
 Why?
Reference Standards
1
2009
164
0.030
 Why?
Quality Control
1
2009
184
0.030
 Why?
Drug Stability
1
2009
246
0.030
 Why?
Drug Therapy, Combination
1
2011
995
0.020
 Why?
Infant, Newborn
1
2018
4741
0.020
 Why?
Guideline Adherence
1
2012
512
0.020
 Why?
Predictive Value of Tests
1
2012
1913
0.020
 Why?
Mutation
1
2017
3174
0.020
 Why?
Mice
1
2002
14765
0.020
 Why?
Expert Testimony
1
2005
52
0.020
 Why?
Clinical Competence
1
2012
870
0.020
 Why?
Drug Tolerance
1
2004
156
0.020
 Why?
Algorithms
1
2011
1464
0.020
 Why?
Receptors, Calcium-Sensing
1
2003
7
0.020
 Why?
Hypercalcemia
1
2003
21
0.020
 Why?
Particle Size
1
2005
402
0.020
 Why?
Triglycerides
1
2005
540
0.020
 Why?
Risk Assessment
1
2012
2934
0.020
 Why?
Receptors, Cell Surface
1
2003
390
0.010
 Why?
Injections, Intravenous
1
2000
266
0.010
 Why?
Albuminuria
1
2000
196
0.010
 Why?
Joy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (374) concept(s)
_
Co-Authors Expand Description
See all (21) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)